358 related articles for article (PubMed ID: 23759384)
1. Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
Villa R; Cerroni B; Viganò L; Margheritelli S; Abolafio G; Oddo L; Paradossi G; Zaffaroni N
Colloids Surf B Biointerfaces; 2013 Oct; 110():434-42. PubMed ID: 23759384
[TBL] [Abstract][Full Text] [Related]
2. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
3. Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cells.
Garg M; Madan J; Pandey RS; Sardana S; Katyal A; Chandra R
Anticancer Drugs; 2012 Sep; 23(8):836-45. PubMed ID: 22407250
[TBL] [Abstract][Full Text] [Related]
4. Polymer shelled microparticles for a targeted doxorubicin delivery in cancer therapy.
Cerroni B; Chiessi E; Margheritelli S; Oddo L; Paradossi G
Biomacromolecules; 2011 Mar; 12(3):593-601. PubMed ID: 21235225
[TBL] [Abstract][Full Text] [Related]
5. Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin.
Duan C; Gao J; Zhang D; Jia L; Liu Y; Zheng D; Liu G; Tian X; Wang F; Zhang Q
Biomacromolecules; 2011 Dec; 12(12):4335-43. PubMed ID: 22077387
[TBL] [Abstract][Full Text] [Related]
6. Galactosylated chitosan-grafted multiwall carbon nanotubes for pH-dependent sustained release and hepatic tumor-targeted delivery of doxorubicin in vivo.
Qi X; Rui Y; Fan Y; Chen H; Ma N; Wu Z
Colloids Surf B Biointerfaces; 2015 Sep; 133():314-22. PubMed ID: 26123852
[TBL] [Abstract][Full Text] [Related]
7. Efficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactions.
Ding J; Xiao C; Li Y; Cheng Y; Wang N; He C; Zhuang X; Zhu X; Chen X
J Control Release; 2013 Aug; 169(3):193-203. PubMed ID: 23247039
[TBL] [Abstract][Full Text] [Related]
8. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
9. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
Tinkov S; Winter G; Coester C; Bekeredjian R
J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
[TBL] [Abstract][Full Text] [Related]
10. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
Cao W; Zhou J; Mann A; Wang Y; Zhu L
Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of pH-responsive chitosan nanocapsules for the controlled delivery of doxorubicin.
Chen CK; Wang Q; Jones CH; Yu Y; Zhang H; Law WC; Lai CK; Zeng Q; Prasad PN; Pfeifer BA; Cheng C
Langmuir; 2014 Apr; 30(14):4111-9. PubMed ID: 24665861
[TBL] [Abstract][Full Text] [Related]
12. Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib.
Duan W; Liu Y
Drug Des Devel Ther; 2018; 12():2149-2161. PubMed ID: 30034219
[TBL] [Abstract][Full Text] [Related]
13. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor cells through chitosan-folate modified microcapsules loaded with camptothecin.
Galbiati A; Tabolacci C; Morozzo Della Rocca B; Mattioli P; Beninati S; Paradossi G; Desideri A
Bioconjug Chem; 2011 Jun; 22(6):1066-72. PubMed ID: 21545180
[TBL] [Abstract][Full Text] [Related]
15. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery.
Lv J; Sun H; Zou Y; Meng F; Dias AA; Hendriks M; Feijen J; Zhong Z
Biomater Sci; 2015 Jul; 3(7):1134-46. PubMed ID: 26221946
[TBL] [Abstract][Full Text] [Related]
16. Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluation.
Wei W; Yue ZG; Qu JB; Yue H; Su ZG; Ma GH
Nanomedicine (Lond); 2010 Jun; 5(4):589-96. PubMed ID: 20528454
[TBL] [Abstract][Full Text] [Related]
17. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
Du JZ; Du XJ; Mao CQ; Wang J
J Am Chem Soc; 2011 Nov; 133(44):17560-3. PubMed ID: 21985458
[TBL] [Abstract][Full Text] [Related]
18. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.
Yang Y; Yuan SX; Zhao LH; Wang C; Ni JS; Wang ZG; Lin C; Wu MC; Zhou WP
Mol Pharm; 2015 Feb; 12(2):644-52. PubMed ID: 25495890
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells.
Tomuleasa C; Soritau O; Orza A; Dudea M; Petrushev B; Mosteanu O; Susman S; Florea A; Pall E; Aldea M; Kacso G; Cristea V; Berindan-Neagoe I; Irimie A
J Gastrointestin Liver Dis; 2012 Jun; 21(2):187-96. PubMed ID: 22720309
[TBL] [Abstract][Full Text] [Related]
20. Liposomes for targeting hepatocellular carcinoma: use of conjugated arabinogalactan as targeting ligand.
Shah SM; Goel PN; Jain AS; Pathak PO; Padhye SG; Govindarajan S; Ghosh SS; Chaudhari PR; Gude RP; Gopal V; Nagarsenker MS
Int J Pharm; 2014 Dec; 477(1-2):128-39. PubMed ID: 25311181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
